Also looks like they recognized income tax expense if I am guessing correctly.
Also had this bit
"The Company expects to launch its next patient compliance and persistency support program with a major pharmaceutical manufacturer during the quarter ending June 30, 2009. The program will be an integral part of a new indication of an existing self-injected drug and is expected to contribute approximately $500 thousand to the Company's fourth quarter revenue."
Sounds like the meat of that 40 million contract won't ramp up for 2 quarters however when it does you ought to see eps in the .15 to .20 range. the cc should be interesting.
When posting on VMC boards all postings should have a symbol in the header and if foreign please post both US and Foreign symbols.
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM